Abstract

Mast cells (MCs) are key effector cells of IgE-FcεRI- or MrgprX2-mediated signaling event. Shuang-Huang-Lian (SHL), a herbal formula from Chinese Pharmacopoeia, has been clinically used in type I hypersensitivity. Our previous study demonstrated that SHL exerted a non-negligible effect on MC stabilization. Herein, we sought to elucidate the molecular mechanisms of the prominent anti-allergic ability of SHL. MrgprX2- and IgE-FcεRI-mediated MC activation in vitro and in vivo models were developed by using compound 48/80 (C48/80) and shrimp tropomyosin (ST), respectively. Our data showed that SHL markedly dampened C48/80- or ST-induced MC degranulation in vitro and in vivo. Mechanistic study indicated that cytosolic Ca2+ (Ca2+[c]) level decreased rapidly and sustainably after SHL treatment, and then returned to homeostasis when SHL was withdrawn. Moreover, SHL decreases Ca2+[c] levels mainly through enhancing the mitochondrial Ca2+ (Ca2+[m]) uptake. After genetically silencing or pharmacologic inhibiting mitochondrial calcium uniporter (MCU), the effect of SHL on the Ca2+[c] level and MC degranulation was significantly weakened. Simultaneously, the activation of SHL on Ca2+[m] uptake was completely lost. Collectively, by activating MCU, SHL decreases Ca2+[c] level to stabilize MCs, thus exerting a remarkable anti-allergic activity, which could have considerable influences on clinical practice and research.

Highlights

  • It is known that the uniporter is a multi-subunit Ca2+ channel, with the Ca2+ pore formed by mitochondrial calcium uniporter (MCU) protein[14,15] and accessory proteins, including MICU116, MICU217, MCUb18, MCUR119 and EMRE20

  • For the first time, SHL potently stabilizes Mast cells (MCs) through decreasing Ca2+[c] level by activating MCU independent of Ca2+[c] rise, which is different from the conventional MC stabilizers

  • MCs are key effector cells that can act as potent initiators and amplifiers in allergy, immunity, and inflammation by secreting multiple mediators[6,42]

Read more

Summary

Introduction

After genetically silencing or pharmacologic inhibiting mitochondrial calcium uniporter (MCU), the effect of SHL on the Ca2+[c] level and MC degranulation was significantly weakened. By activating MCU, SHL decreases Ca2+[c] level to stabilize MCs, exerting a remarkable anti-allergic activity, which could have considerable influences on clinical practice and research. IgE-FcεRI- or MrgprX2-mediated MC signaling event, eventually results in the activation of protein kinase C (PKC) and the release of Ca2+ from the endoplasmic reticulum (ER), which in turn induces the stromal interaction molecule 1-mediated opening of the store-operated Ca2+ channel ORAI1 and leads to the influx of extracellular Ca2+. For the first time, SHL potently stabilizes MCs through decreasing Ca2+[c] level by activating MCU independent of Ca2+[c] rise, which is different from the conventional MC stabilizers (e.g., cromolyn sodium and ketotifen)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call